Clinical Trial: Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Randomized, Single-blinded, Placebo-controlled, Single-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of RN0191 in Adult Subjects W
Brief Summary:
Objectives: The primary and secondary objectives of the study are presented below.Exploratory objectives are presented in the body of the protocol.Primary:• To determine the safety and tolerability of RN0191 administered as escalating single subcutaneously (SC) doses in adult subjects with elevated low-density lipoprotein-cholesterolSecondary:To evaluate the single-dose pharmacokinetics (PK) of RN0191 in adult subjects with elevated low-density lipoprotein-cholesterolTo evaluate the pharmacodynamic (PD) effect of…
Read more